CLSN
Price:
$1.9466
Market Cap:
$5.71M
Imunon, Inc. is a biotechnology firm in the clinical development stage, dedicated to innovating and commercializing DNA-centric immunotherapies, vaccines, and targeted chemotherapy solutions. Its primary pipeline assets include GEN-1, a DNA-based immunotherapy specifically designed for the localized treatment of ovarian cancer, and ThermoDox, a unique formulation of doxorubicin encapsulated in heat-activated liposomes, currently being assessed for a variety of cancer indications. Furthermore, the company is advancing two early-phase platform technologies aimed at developing nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA treatments. Established in 1982, Imunon,...[Read more]
Industry
Biotechnology
IPO Date
1993-10-27
Stock Exchange
NASDAQ
Ticker
CLSN
According to Imunon, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.49. This represents a change of -40.23% compared to the average of -0.82 of the last 4 quarters.
The mean historical PE Ratio of Imunon, Inc. over the last ten years is -0.98. The current -0.49 PE Ratio has changed 4.89% with respect to the historical average. Over the past ten years (40 quarters), CLSN's PE Ratio was at its highest in in the December 2018 quarter at 1.39. The PE Ratio was at its lowest in in the September 2016 quarter at -19.89.
Average
-0.98
Median
-0.62
Minimum
-2.55
Maximum
-0.16
Discovering the peaks and valleys of Imunon, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 193.72%
Maximum Annual PE Ratio = -0.16
Minimum Annual Increase = -86.64%
Minimum Annual PE Ratio = -2.55
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.56 | -17.40% |
| 2024 | -0.68 | 86.32% |
| 2023 | -0.36 | 17.33% |
| 2022 | -0.31 | 90.38% |
| 2021 | -0.16 | -86.64% |
| 2020 | -1.21 | -52.32% |
| 2019 | -2.55 | 6.19% |
| 2018 | -2.40 | 101.25% |
| 2017 | -1.19 | 193.72% |
| 2016 | -0.41 | -81.07% |
The current PE Ratio of Imunon, Inc. (CLSN) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.53
5-year avg
-0.41
10-year avg
-0.98
Imunon, Inc.’s PE Ratio is less than Celyad Oncology S.A. (11.65), less than Kineta, Inc. (-0.40), less than Reunion Neuroscience Inc. (-0.34), less than SQZ Biotechnologies Company (-0.01), less than Alpha Compute Corp (-0.01), greater than Axcella Health Inc. (-3.61), less than Notable Labs, Ltd. (-0.05), greater than TuHURA Biosciences, Inc. (-3.89), greater than Talphera, Inc. (-3.63), less than Anew Medical, Inc. (5.19),
| Company | PE Ratio | Market cap |
|---|---|---|
| 11.65 | $14.24M | |
| -0.40 | $7.05M | |
| -0.34 | $13.12M | |
| -0.01 | $707.79K | |
| -0.01 | $666.63K | |
| -3.61 | $12.50M | |
| -0.05 | $2.39M | |
| -3.89 | $133.73M | |
| -3.63 | $60.20M | |
| 5.19 | $15.44M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Imunon, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Imunon, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Imunon, Inc.'s PE Ratio?
How is the PE Ratio calculated for Imunon, Inc. (CLSN)?
What is the highest PE Ratio for Imunon, Inc. (CLSN)?
What is the 3-year average PE Ratio for Imunon, Inc. (CLSN)?
What is the 5-year average PE Ratio for Imunon, Inc. (CLSN)?
How does the current PE Ratio for Imunon, Inc. (CLSN) compare to its historical average?